These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12932588)

  • 1. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
    Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
    J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries.
    Ulus T; Parspour A; Cavusoglu Y; Entok E; Uslu I; Demirustu C
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):328-34. PubMed ID: 22530349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
    Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
    J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.
    Dangas G; Badimon JJ; Smith DA; Unger AH; Levine D; Shao JH; Meraj P; Fier C; Fallon JT; Ambrose JA
    J Am Coll Cardiol; 1999 Apr; 33(5):1294-304. PubMed ID: 10193730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.
    Ling MC; Ruddy TD; deKemp RA; Ukkonen H; Duchesne L; Higginson L; Williams KA; McPherson R; Beanlands R
    Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
    Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the relationship between myocardial perfusion and lipid-lowering.
    Blumenthal RS; Gluckman TJ
    J Am Coll Cardiol; 2003 Aug; 42(4):611-3. PubMed ID: 12932589
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.
    Sakamoto K; Sakamoto T; Ogawa H;
    Clin Ther; 2006 Jul; 28(7):1012-21. PubMed ID: 16990079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty.
    Manfrini O; Pizzi C; Morgagni G; Fontana F; Bugiardini R
    Am J Cardiol; 2004 Jun; 93(11):1391-3, A6. PubMed ID: 15165921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS).
    Aengevaeren WR; Uijen GJ; Jukema JW; Bruschke AV; van der Werf T
    Circulation; 1997 Jul; 96(2):429-35. PubMed ID: 9244208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
    Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a HMG-CoA reductase inhibitor combined with hormone replacement therapy on lipid metabolism in Japanese women with hypoestrogenic lipidemia: a multicenter double-blind controlled prospective study.
    Ohta H; Komukai S; Sugimoto I; Fuyuki T; Makita K; Takamatsu K; Horiguchi F; Nozawa S
    Maturitas; 1998 Jun; 29(2):163-71. PubMed ID: 9651906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early resting myocardial computed tomography perfusion for the detection of acute coronary syndrome in patients with coronary artery disease.
    Pursnani A; Lee AM; Mayrhofer T; Ahmed W; Uthamalingam S; Ferencik M; Puchner SB; Bamberg F; Schlett CL; Udelson J; Hoffmann U; Ghoshhajra BB
    Circ Cardiovasc Imaging; 2015 Mar; 8(3):e002404. PubMed ID: 25752898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiovascular medication after coronary artery calcium scanning and normal single photon emission computed tomography myocardial perfusion imaging in symptomatic patients.
    Engbers EM; Timmer JR; Mouden M; Knollema S; Jager PL; Ottervanger JP
    Am Heart J; 2017 Apr; 186():56-62. PubMed ID: 28454833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
    Rahman M; Baimbridge C; Davis BR; Barzilay JI; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
    Clin Nephrol; 2013 Oct; 80(4):235-48. PubMed ID: 23816477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing angiographic progression of coronary atherosclerosis with pravastatin.
    Daida H; Ouchi Y; Saito Y; Yamada N; Nishide T; Mokuno H; Kurata T; Sato H; Eto M; Ako JY; Tango T; Yamaguchi H;
    J Atheroscler Thromb; 2003; 10(1):25-31. PubMed ID: 12621161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.